Paediatric metastatic ganglioneuroblastoma on 68Ga-DOTA NOC PET-CT

Affiliations

01 January 2023

-

doi: 10.47391/JPMA.07-23


Abstract

68Ga-DOTA NOC PET-CT imaging has been shown to have high accuracy for the evaluation of neuroendocrine tumours. We report a case of a 3-year-old boy who presented with a right paravertebral soft tissue mass. Biopsy showed ganglioneuroblastoma. The patient was referred for 68Ga-DOTA NOC for staging. 68Ga-DOTA NOC PET/CT images showed somatostatin-avid large right paravertebral soft tissue mass representing the primary lesion, along with increased radiotracer localization at multiple metastatic lytic bone lesions in the axial and appendicular skeleton. 68Ga-DOTA NOC PET-CT is helpful in the evaluation of the disease extent of neuroendocrine tumours including ganglioneuroblastoma.

Keywords: 68Ga-DOTA NOC PET-CT, ganglioneuro blastoma, neuroendocrine tumours, PET/CT..


Similar articles

The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.

Haidar M, Shamseddine A, Panagiotidis E, Jreige M, Mukherji D, Assi R, Abousaid R, Ibrahim T, Haddad MM, Vinjamuri S.Nucl Med Commun. 2017 Feb;38(2):170-177. doi: 10.1097/MNM.0000000000000623.PMID: 27922538

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

Fanti S, Ambrosini V, Tomassetti P, Castellucci P, Montini G, Allegri V, Grassetto G, Rubello D, Nanni C, Franchi R.Biomed Pharmacother. 2008 Dec;62(10):667-71. doi: 10.1016/j.biopha.2008.01.010. Epub 2008 Mar 3.PMID: 18358680

Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants.

Kagna O, Pirmisashvili N, Tshori S, Freedman N, Israel O, Krausz Y.AJR Am J Roentgenol. 2014 Dec;203(6):1317-23. doi: 10.2214/AJR.14.12588.PMID: 25415711

The use of gallium-68 labeled somatostatin receptors in PET/CT imaging.

Ambrosini V, Nanni C, Fanti S.PET Clin. 2014 Jul;9(3):323-9. doi: 10.1016/j.cpet.2014.03.008. Epub 2014 Apr 26.PMID: 25030395 Review.

Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.

Ryzhkova D, Mitrofanova L, Tsoy U, Grineva E, Schlyakhto E.Front Endocrinol (Lausanne). 2022 Sep 5;13:958442. doi: 10.3389/fendo.2022.958442. eCollection 2022.PMID: 36133304 Free PMC article. Review.


KMEL References